NCT02306824View on ClinicalTrials.gov

Berlin Atrial Fibrillation Registry

CompletedOBSERVATIONAL
Enrollment

1,080

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2020

Conditions
Acute Ischemic StrokeAtrial Fibrillation
Trial Locations (1)

Unknown

Charité - Universitätsmedizin Berlin, Berlin

Sponsors
All Listed Sponsors
collaborator

Center for Stroke Research Berlin

OTHER

collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER

NCT02306824 - Berlin Atrial Fibrillation Registry | Biotech Hunter | Biotech Hunter